Ladenburg Thalmann Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $8.75M | Buy |
70,605
+383
| +0.5% | +$47.5K | 0.06% | 332 |
|
|
2019
Q3 | $4.66M | Buy |
70,222
+68,123
| +3,245% | +$4.52M | 0.03% | 486 |
|
|
2019
Q2 | $168K | Sell |
2,099
-859
| -29% | -$68.8K | ﹤0.01% | 2590 |
|
|
2019
Q1 | $331K | Buy |
2,958
+603
| +26% | +$67.5K | ﹤0.01% | 2008 |
|
|
2018
Q4 | $236K | Sell |
2,355
-5,244
| -69% | -$526K | ﹤0.01% | 2113 |
|
|
2018
Q3 | $961K | Sell |
7,599
-8,823
| -54% | -$1.12M | 0.01% | 1141 |
|
|
2018
Q2 | $1.01M | Hold |
16,422
| – | – | 0.01% | 1066 |
|
|
2018
Q1 | $1.01M | Buy |
16,422
+10,007
| +156% | +$615K | 0.01% | 1066 |
|
|
2017
Q4 | $375K | Sell |
6,415
-1,167
| -15% | -$68.2K | ﹤0.01% | 1748 |
|
|
2017
Q3 | $440K | Buy |
7,582
+5,648
| +292% | +$328K | ﹤0.01% | 1553 |
|
|
2017
Q2 | $234K | Buy |
1,934
+400
| +26% | +$48.4K | ﹤0.01% | 1905 |
|
|
2017
Q1 | $173K | Sell |
1,534
-96
| -6% | -$10.8K | ﹤0.01% | 2022 |
|
|
2016
Q4 | $178K | Buy |
1,630
+462
| +40% | +$50.5K | ﹤0.01% | 1898 |
|
|
2016
Q3 | $193K | Buy |
1,168
+12
| +1% | +$1.98K | ﹤0.01% | 1786 |
|
|
2016
Q2 | $165K | Buy |
1,156
+352
| +44% | +$50.2K | ﹤0.01% | 1806 |
|
|
2016
Q1 | $103K | Buy |
804
+1
| +0.1% | +$128 | ﹤0.01% | 2045 |
|
|
2015
Q4 | $120K | Buy |
803
+19
| +2% | +$2.84K | ﹤0.01% | 1930 |
|
|
2015
Q3 | $130K | Buy |
784
+102
| +15% | +$16.9K | ﹤0.01% | 1799 |
|
|
2015
Q2 | $165K | Sell |
682
-60
| -8% | -$14.5K | ﹤0.01% | 1743 |
|
|
2015
Q1 | $209K | Buy |
742
+60
| +9% | +$16.9K | ﹤0.01% | 1546 |
|
|
2014
Q4 | $106K | Sell |
682
-125
| -15% | -$19.4K | ﹤0.01% | 1855 |
|
|
2014
Q3 | $191K | Buy |
807
+276
| +52% | +$65.3K | 0.01% | 1237 |
|
|
2014
Q2 | $126K | Buy |
531
+431
| +431% | +$102K | ﹤0.01% | 1459 |
|
|
2014
Q1 | $33K | Buy |
+100
| New | +$33K | ﹤0.01% | 2239 |
|